Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
The Lancet. Neurology
|
April 13, 2016
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson, Ronald Lautner, Ulf Andreasson, et al.
Alzheimer'S Research & Therapy
|
October 25, 2017
Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations
Ronald Lautner, Philip S Insel, Tobias Skillbäck, et al.
Metabolism: Clinical and Experimental
|
January 15, 2010
Preliminary report: Zn-alpha2-glycoprotein genotype and serum levels are associated with serum lipids
Louise E Olofsson, Bob Olsson, Theodore Lystig, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 16, 2009
Tenomodulin is highly expressed in adipose tissue, increased in obesity, and down-regulated during diet-induced weight loss
Atsuhito Saiki, Maja Olsson, Margareta Jernås, et al.
JAMA Psychiatry
|
August 28, 2014
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease
Ronald Lautner, Sebastian Palmqvist, Niklas Mattsson, et al.
Diabetes
|
December 24, 2004
Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia
Mohammad Bohlooly-Y, Mohammad Bohlooly, Bob Olsson, et al.
Obesity (Silver Spring, Md.)
|
July 16, 2011
Association of sirtuin 1 (SIRT1) gene SNPs and transcript expression levels with severe obesity
Stephen J Clark, Mario Falchi, Bob Olsson, et al.
JAMA Neurology
|
December 4, 2018
Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders
Bob Olsson, Erik Portelius, Nicholas C Cullen, et al.
Acta Neuropathologica
|
April 28, 2018
Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology
Erik Portelius, Bob Olsson, Kina Höglund, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 16, 2018
Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology
Åsa Sandelius, Erik Portelius, Åsa Källén, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
The Lancet. Neurology
|
April 13, 2016
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson, Ronald Lautner, Ulf Andreasson, et al.
Alzheimer'S Research & Therapy
|
October 25, 2017
Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations
Ronald Lautner, Philip S Insel, Tobias Skillbäck, et al.
Metabolism: Clinical and Experimental
|
January 15, 2010
Preliminary report: Zn-alpha2-glycoprotein genotype and serum levels are associated with serum lipids
Louise E Olofsson, Bob Olsson, Theodore Lystig, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 16, 2009
Tenomodulin is highly expressed in adipose tissue, increased in obesity, and down-regulated during diet-induced weight loss
Atsuhito Saiki, Maja Olsson, Margareta Jernås, et al.
JAMA Psychiatry
|
August 28, 2014
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease
Ronald Lautner, Sebastian Palmqvist, Niklas Mattsson, et al.
Diabetes
|
December 24, 2004
Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia
Mohammad Bohlooly-Y, Mohammad Bohlooly, Bob Olsson, et al.
Obesity (Silver Spring, Md.)
|
July 16, 2011
Association of sirtuin 1 (SIRT1) gene SNPs and transcript expression levels with severe obesity
Stephen J Clark, Mario Falchi, Bob Olsson, et al.
JAMA Neurology
|
December 4, 2018
Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders
Bob Olsson, Erik Portelius, Nicholas C Cullen, et al.
Acta Neuropathologica
|
April 28, 2018
Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology
Erik Portelius, Bob Olsson, Kina Höglund, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 16, 2018
Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology
Åsa Sandelius, Erik Portelius, Åsa Källén, et al.
Page
of 8